Stephen Maxted Ansell, MD, PhD

  • 21180 Citations
  • 78 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

Filter
Article
2011
27 Citations (Scopus)

GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment

Elsawa, S. F., Almada, L. L., Ziesmer, S. C., Novak, A. J., Witzig, T. E., Ansell, S. M. & Fernandez-Zapico, M. E., Jun 17 2011, In : Journal of Biological Chemistry. 286, 24, p. 21524-21534 11 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Tumors
Transcription Factors
Cells
Cytokines
4 Citations (Scopus)

Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine

Ansell, S. M. & Suman, V. J., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2748-2749 2 p.

Research output: Contribution to journalArticle

Immunoglobulin Idiotypes
Follicular Lymphoma
Cancer Vaccines
Patient Selection
Vaccines

Innate immune B cells gone bad

Ansell, S. M., Nov 7 2011, In : Oncology. 25, 12

Research output: Contribution to journalArticle

B-Lymphocytes

Innate immune B cells gone bad.

Ansell, S. M., Nov 15 2011, In : Oncology (Williston Park, N.Y.). 25, 12

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
B-Lymphocytes
13 Citations (Scopus)

Jak/stat pathway in Waldenström's macroglobulinemia

Hodge, L. S. & Ansell, S. M., Feb 1 2011, In : Clinical Lymphoma, Myeloma and Leukemia. 11, 1, p. 112-114 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Cytokines
Autocrine Communication
Paracrine Communication
82 Citations (Scopus)

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: Phase i study

Nowakowski, G. S., Laplant, B., Habermann, T. M., Rivera, C. E., MacOn, W. R., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Ansell, S. M., Klebig, R. R., Reeder, C. B. & Witzig, T. E., Dec 2011, In : Leukemia. 25, 12, p. 1877-1881 5 p.

Research output: Contribution to journalArticle

Vincristine
B-Cell Lymphoma
Prednisone
Doxorubicin
Cyclophosphamide
5 Citations (Scopus)

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization

Naina, H. V., Pruthi, R. K., Inwards, D. J., Dingli, D. M., Litzow, M. R., Ansell, S. M., Hogan, W., Dispenzieri, A., Buadi, F. K., Elliott, M. A., Gastineau, D. A., Gertz, M., Hayman, S. R., Johnston, P. B., Lacy, M., Micallef, I., Porrata, L. F. & Kumar, S. K., Feb 2011, In : Bone Marrow Transplantation. 46, 2, p. 291-293 3 p.

Research output: Contribution to journalArticle

Intercellular Signaling Peptides and Proteins
Granulocytes
Thrombosis
Amyloidosis
Multiple Myeloma
13 Citations (Scopus)

MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts

Hodge, L. S., Elsawa, S. F., Grote, D. M., Price-Troska, T. L., Asmann, Y., Fonseca, R., Gertz, M., Witzig, T. E., Novak, A. J. & Ansell, S. M., Jun 2011, In : Blood Cancer Journal. 1, 6, e24.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
MicroRNAs
Neoplasms
B-Lymphocytes
Hematopoiesis
30 Citations (Scopus)

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Witzig, T. E., Tang, H., Micallef, I., Ansell, S. M., Link, B. K., Inwards, D. J., Porrata, L. F., Johnston, P. B., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Thompson, C. A., Allmer, C., Maurer, M. J., Gupta, M., Weiner, G., Hohl, R., Kurtin, P. J., Ding, H., Loegering, D. & 4 others, Schneider, P., Peterson, K., Habermann, T. M. & Kaufmann, S. H., Nov 3 2011, In : Blood. 118, 18, p. 4882-4889 8 p.

Research output: Contribution to journalArticle

tipifarnib
Farnesyltranstransferase
Refractory materials
Non-Hodgkin's Lymphoma
Lymphoma
37 Citations (Scopus)

Novel therapeutic agents for B-cell lymphoma: Developing rational combinations

Reeder, C. B. & Ansell, S. M., Feb 3 2011, In : Blood. 117, 5, p. 1453-1462 10 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Cells
Critical Pathways
Tumor Microenvironment
46 Citations (Scopus)

Predicting PBSC harvest failure using circulating CD34 levels: Developing target-based cutoff points for early intervention

Sinha, S., Gastineau, D., Micallef, I., Hogan, W., Ansell, S. M., Buadi, F., Dingli, D. M., Dispenzieri, A., Gertz, M., Greiner, C., Hayman, S., Inwards, D., Johnston, P. B., Lacy, M., Litzow, M. R., Porrata, L., Winters, J. L. & Kumar, S. K., Jul 2011, In : Bone Marrow Transplantation. 46, 7, p. 943-949 7 p.

Research output: Contribution to journalArticle

Granulocyte Colony-Stimulating Factor
Hodgkin Disease
Non-Hodgkin's Lymphoma
Blood Component Removal
Amyloidosis
33 Citations (Scopus)

Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

Wada, D. A., Wilcox, R. A., Harrington, S. M., Kwon, E. D., Ansell, S. M. & Comfere, N. I., Mar 2011, In : American Journal of Hematology. 86, 3, p. 325-327 3 p.

Research output: Contribution to journalArticle

Neoplasm Proteins
CD Antigens
Sezary Syndrome
Mycosis Fungoides
Apoptosis Regulatory Proteins
71 Citations (Scopus)

Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Manske, M. K., Witzig, T. E., Novak, A. J. & Ansell, S. M., Sep 8 2011, In : Blood. 118, 10, p. 2809-2820 12 p.

Research output: Contribution to journalArticle

Interleukin-2 Receptors
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Interleukin-2
T-cells
97 Citations (Scopus)

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: A multicenter study of 204 skin biopsies

Wada, D. A., Law, M. E., Hsi, E. D., Dicaudo, D. J., Ma, L., Lim, M. S., De Souza, A., Comfere, N. I., Weenig, R. H., MacOn, W. R., Erickson, L. A., Özsan, N., Ansell, S. M., Dogan, A. & Feldman, A. L., Apr 2011, In : Modern Pathology. 24, 4, p. 596-605 10 p.

Research output: Contribution to journalArticle

Primary Cutaneous Anaplastic Large Cell Lymphoma
Anaplastic Large-Cell Lymphoma
Multicenter Studies
Lymphoproliferative Disorders
Biopsy
123 Citations (Scopus)

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 study

Ansell, S. M., Tang, H., Kurtin, P. J., Koenig, P. A., Inwards, D. J., Shah, K., Ziesmer, S. C., Feldman, A. L., Rao, R., Gupta, M., Erlichman, C. & Witzig, T. E., Apr 2011, In : The Lancet Oncology. 12, 4, p. 361-368 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Sirolimus
temsirolimus
Rituximab
Pneumonia
115 Citations (Scopus)

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma

Wilcox, R. A., Ristow, K., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Colgan, J. P., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., Markovic, S. N. & Porrata, L., Sep 2011, In : Leukemia. 25, 9, p. 1502-1509 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Lymphocytes
Survival
1 Citation (Scopus)

The definition of IgM multiple myeloma

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Aug 2011, In : American Journal of Hematology. 86, 8, p. 718-719 2 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Immunoglobulin M
2010
58 Citations (Scopus)

A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling

Hildebrand, J. M., Luo, Z., Manske, M. K., Price-Troska, T., Ziesmer, S. C., Lin, W., Hostager, B. S., Slager, S. L., Witzig, T. E., Ansell, S. M., Cerhan, J. R., Bishop, G. A. & Novak, A. J., Nov 22 2010, In : Journal of Experimental Medicine. 207, 12, p. 2569-2579 11 p.

Research output: Contribution to journalArticle

B-Cell Activation Factor Receptor
Non-Hodgkin's Lymphoma
Mutation
TNF Receptor-Associated Factor 6
TNF Receptor-Associated Factor 3
99 Citations (Scopus)

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

Younes, A., Vose, J. M., Zelenetz, A. D., Smith, M. R., Burris, H. A., Ansell, S. M., Klein, J., Halpern, W., Miceli, R., Kumm, E., Fox, N. L. & Czuczman, M. S., Dec 7 2010, In : British Journal of Cancer. 103, 12, p. 1783-1787 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Follicular Lymphoma
TNF-Related Apoptosis-Inducing Ligand Receptors
Staining and Labeling
Disease Progression
26 Citations (Scopus)

A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D. M., Laumann, K. M., Allred, J., Geyer, S. M., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Micallef, I., Ansell, S. M., Porrata, L., Elliott, M. A., Johnston, P. B., Hogan, W. & Gertz, M., Jun 2010, In : American Journal of Hematology. 85, 6, p. 409-413 5 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Radiopharmaceuticals
Hematopoietic Stem Cells
Disease-Free Survival

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I. N., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus
170 Citations (Scopus)

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 1 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus

Author reply: Flows and flaws in primary CNS lymphoma

Ansell, S. M. & Rajkumar, S. V., Aug 2010, In : Nature Reviews Clinical Oncology. 7, 8

Research output: Contribution to journalArticle

Lymphoma
76 Citations (Scopus)

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: A status report

Gertz, M., Lacy, M., Dispenzieri, A., Hayman, S. R., Kumar, S. K., Dingli, D. M., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Johnston, P. B., Litzow, M. R., Micallef, I., Porrata, L. F., Leung, N., Hogan, W. & Buadi, F. K., Dec 2010, In : Leukemia and Lymphoma. 51, 12, p. 2181-2187 7 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Stem Cells
Transplants
Survival
11 Citations (Scopus)
Chimerism
Melphalan
Hematologic Neoplasms
Tissue Donors
Survival
58 Citations (Scopus)

Comparison of error rates in single-arm versus randomized phase II cancer clinical trials

Tang, H., Foster, N. R., Grothey, A. F., Ansell, S. M., Goldberg, R. M. & Sargent, D. J., Apr 10 2010, In : Journal of Clinical Oncology. 28, 11, p. 1936-1941 6 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Randomized Controlled Trials
Patient Selection
Neoplasms
Statistical Models
103 Citations (Scopus)

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M., 2010, In : Mayo Clinic Proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Guidelines
Therapeutics
Immunoglobulin M
Plasmapheresis
28 Citations (Scopus)

Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma

Kelly, J. L., Novak, A. J., Fredericksen, Z. S., Liebow, M., Ansell, S. M., Dogan, A., Wang, A. H., Witzig, T. E., Call, T. G., Kay, N. E., Habermann, T. M., Slager, S. L. & Cerhan, J. R., Nov 2010, In : Cancer Epidemiology Biomarkers and Prevention. 19, 11, p. 2847-2858 12 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Apoptosis
Single Nucleotide Polymorphism
Genes
Genetic Translocation
6 Citations (Scopus)

Hematology: Trials and tribulations in primary CNS lymphoma

Ansell, S. M. & Rajkumar, S. V., Mar 2010, In : Nature Reviews Clinical Oncology. 7, 3, p. 125-126 2 p.

Research output: Contribution to journalArticle

Central Nervous System Neoplasms
Hematology
Antineoplastic Agents
Non-Hodgkin's Lymphoma
Lymphoma
51 Citations (Scopus)

IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Nov 2010, In : American Journal of Hematology. 85, 11, p. 853-855 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Immunoglobulin M
Plasma Cells
Bone and Bones
34 Citations (Scopus)

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

Wilcox, R. A., Sun, D. X., Novak, A. J., Dogan, A., Ansell, S. M. & Feldman, A. L., Jan 2010, In : Leukemia. 24, 1, p. 229-232 4 p.

Research output: Contribution to journalArticle

Intracellular Signaling Peptides and Proteins
T-Cell Lymphoma
Tumor Cell Line
Protein-Tyrosine Kinases
Non-Hodgkin's Lymphoma
15 Citations (Scopus)
Interleukin-15
Hematopoietic Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation
Natural Killer Cells
Non-Hodgkin's Lymphoma
40 Citations (Scopus)
Lymphopenia
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Recurrence
Drug Therapy
24 Citations (Scopus)
Peripheral Blood Stem Cell Transplantation
Lymphopenia
Lymphoma, Large B-Cell, Diffuse
Hematopoietic Stem Cell Transplantation
Lymphocyte Count
107 Citations (Scopus)

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory waldenström macroglobulinemia

Ghobrial, I. M., Gertz, M., LaPlant, B., Camoriano, J. K., Hayman, S., Lacy, M., Chuma, S., Harris, B., Leduc, R., Rourke, M., Ansell, S. M., DeAngelo, D., Dispenzieri, A., Bergsagel, P. L., Reeder, C., Anderson, K. C., Richardson, P. G., Treon, S. P. & Witzig, T. E., Mar 10 2010, In : Journal of Clinical Oncology. 28, 8, p. 1408-1414 7 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Sirolimus
Disease-Free Survival
Everolimus
Phosphatidylinositol 3-Kinase
5 Citations (Scopus)

Phase i trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma

Litzow, M. R., Peethambaram, P. P., Safgren, S. L., Keeney, G., Ansell, S. M., Dispenzieri, A., Elliott, M. A., Gastineau, D. A., Gertz, M., Inwards, D. J., Lacy, M., Micallef, I., Porrata, L. F., Lingle, W. L., Hartmann, L. C., Frost, M. H., Barrette, B. A., Long, H. J., Suman, V. J., Reid, J. M. & 2 others, Ames, M. M. & Kaufmann, S. H., 2010, In : Bone Marrow Transplantation. 45, 3, p. 490-497 8 p.

Research output: Contribution to journalArticle

Topotecan
Carboplatin
Carcinoma
Disease-Free Survival
Type I DNA Topoisomerase
57 Citations (Scopus)

Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era

Nowakowski, G. S., Maurer, M. J., Habermann, T. M., Ansell, S. M., Macon, W. R., Ristow, K. M., Allmer, C., Slager, S. L., Witzig, T. E. & Cerhan, J. R., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 412-417 6 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Rituximab
Disease-Free Survival
150 Citations (Scopus)

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma

Drake, M. M., Maurer, M. J., Link, B. K., Habermann, T. M., Ansell, S. M., Micallef, I., Kelly, J. L., Macon, W. R., Nowakowski, G. S., Inwards, D. J., Johnston, P. B., Singh, R. J., Allmer, C., Slager, S. L., Weiner, G. J., Witzig, T. E. & Cerhan, J. R., Sep 20 2010, In : Journal of Clinical Oncology. 28, 27, p. 4191-4198 8 p.

Research output: Contribution to journalArticle

Vitamin D
Non-Hodgkin's Lymphoma
Disease-Free Survival
T-Cell Lymphoma
Survival
2009
38 Citations (Scopus)
Phosphatidylinositol 3-Kinase
Follicular Lymphoma
Cyclin D1
Cell proliferation
Sirolimus
124 Citations (Scopus)

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Wilcox, R. A., Feldman, A. L., Wada, D. A., Yang, Z. Z., Comfere, N. I., Dong, H. M., Kwon, E. D., Novak, A. J., Markovic, S. N., Pittelkow, M. R., Witzig, T. E. & Ansell, S. M., 2009, In : Blood. 114, 10, p. 2149-2158 10 p.

Research output: Contribution to journalArticle

T-cells
Lymphoproliferative Disorders
Non-Hodgkin's Lymphoma
Tumor Microenvironment
Immunity
10 Citations (Scopus)

Cytokines in the microenvironment of Waldenström's macroglobulinemia

Elsawa, S. & Ansell, S. M., 2009, In : Clinical Lymphoma and Myeloma. 9, 1, p. 43-45 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytokines
Immunoglobulins
Tumor Microenvironment
Growth
48 Citations (Scopus)

Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma

Novak, A. J., Slager, S. L., Fredericksen, Z. S., Wang, A. H., Manske, M. M., Ziesmer, S., Liebow, M., Macon, W. R., Dillon, S. R., Witzig, T. E., Cerhan, J. R. & Ansell, S. M., May 15 2009, In : Cancer Research. 69, 10, p. 4217-4224 8 p.

Research output: Contribution to journalArticle

B-Cell Activating Factor
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Alleles
122 Citations (Scopus)
Histone Deacetylases
Lymphoma, Large B-Cell, Diffuse
Sirolimus
Cells
Histone Deacetylase Inhibitors
181 Citations (Scopus)

Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R. & Sargent, D. J., Oct 2009, In : Gastroenterology. 137, 4, p. 1270-1279 10 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Colon
Carcinoma
T-Lymphocytes
Disease-Free Survival
110 Citations (Scopus)

Malignant B cells skew the balance of regulatory T cells and T H17 cells in B-cell non-Hodgkin's lymphoma

Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M., Jul 1 2009, In : Cancer Research. 69, 13, p. 5522-5530 9 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Regulatory T-Lymphocytes
Interleukin-17
Non-Hodgkin's Lymphoma
Interleukin-2
98 Citations (Scopus)

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

Wilcox, R. A., Wada, D. A., Ziesmer, S. C., Elsawa, S. F., Comfere, N. I., Dietz, A. B., Novak, A. J., Witzig, T. E., Feldman, A. L., Pittelkow, M. R. & Ansell, S. M., 2009, In : Blood. 114, 14, p. 2936-2944 9 p.

Research output: Contribution to journalArticle

T-cells
Lymphoproliferative Disorders
Dendritic Cells
Tumors
Monocytes
194 Citations (Scopus)

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

Ansell, S. M., Hurvitz, S. A., Koenig, P. A., LaPlant, B. R., Kabat, B. F., Fernando, D., Habermann, T. M., Inwards, D. J., Verma, M., Yamada, R., Erlichman, C., Lowy, I. & Timmerman, J. M., Oct 15 2009, In : Clinical Cancer Research. 15, 20, p. 6446-6453 8 p.

Research output: Contribution to journalArticle

CTLA-4 Antigen
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
T-Lymphocytes
10 Citations (Scopus)

Risk of non-Hodgkin lymphoma in association with germline variation in complement genes

Cerhan, J. R., Novak, A. J., Fredericksen, Z. S., Wang, A. H., Liebow, M., Call, T. G., Dogan, A., Witzig, T. E., Ansell, S. M., Habermann, T. M., Kay, N. E. & Slager, S. L., Jun 2009, In : British Journal of Haematology. 145, 5, p. 614-623 10 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Single Nucleotide Polymorphism
Genes
Haplotypes
Principal Component Analysis
15 Citations (Scopus)

Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma

Ansell, S. M., Novak, A. J., Ziesmer, S., Price-Troska, T., Laplant, B., Dillon, S. R. & Witzig, T. E., Feb 2009, In : American Journal of Hematology. 84, 2, p. 71-73 3 p.

Research output: Contribution to journalArticle

B-Cell Activating Factor
Non-Hodgkin's Lymphoma
Serum
Therapeutics
B-Lymphocytes
15 Citations (Scopus)

The role of Treg cells in the cancer immunological response

Yang, Z. Z. & Ansell, S. M., 2009, In : American Journal of Immunology. 5, 1, p. 17-28 12 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Neoplasms
Immunity
Allergy and Immunology
T-Lymphocytes